DAVID REGALLA: Open Payments
NPI 1982661468 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 28 payments from 11 companies in 2025. Trend: 2023 $43 · 2024 $492 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 6 | $116 |
| Eisai Inc. | 6 | $111 |
| PFIZER INC. | 5 | $78 |
| SK Life Science, Inc. | 2 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $25 |
| UCB, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: Leqembi, NURTEC ODT, KESIMPTA, Gocovri, PONVORY, AMYVID, Rystiggo, VYEPTI.
Industry payments across PA — which companies pay providers there.
